These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19392720)

  • 1. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communiqué.
    Xenotransplantation; 2009; 16(2):61-3. PubMed ID: 19392720
    [No Abstract]   [Full Text] [Related]  

  • 2. Global consultation on regulatory requirements for xenotransplantation in clinical trials. Conference held in Changsha, China, November 19-21, 2008.
    Cooper DK
    Xenotransplantation; 2009; 16(2):58-60. PubMed ID: 19392719
    [No Abstract]   [Full Text] [Related]  

  • 3. Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12-14, 2018: "The 2018 Changsha Communiqué" The 10-Year Anniversary of The International Consultation on Xenotransplantation.
    Hawthorne WJ; Cowan PJ; Bühler LH; Yi S; Bottino R; Pierson RN; Ahn C; Azimzadeh A; Cozzi E; Gianello P; Lakey JRT; Luo M; Miyagawa S; Mohiuddin MM; Park CG; Schuurman HJ; Scobie L; Sykes M; Tector J; Tönjes RR; Wolf E; Nuñez JR; Wang W
    Xenotransplantation; 2019 Mar; 26(2):e12513. PubMed ID: 30980428
    [No Abstract]   [Full Text] [Related]  

  • 4. National policies for xenotransplantation in the USA.
    Bloom ET
    Xenotransplantation; 2007 Jul; 14(4):345-6. PubMed ID: 17669177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework.
    Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY
    Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partnership of the International Xenotransplantation Association, The Transplantation Society, and World Health Organization in the development of guidance documents and policies for xenotransplantation including the Changsha communiqué.
    Hawthorne WJ
    Xenotransplantation; 2020 May; 27(3):e12604. PubMed ID: 32449210
    [No Abstract]   [Full Text] [Related]  

  • 7. World Health Organization resolution on xenotransplantation.
    Sykes M; Sandrin M; Cozzi E; Rees MA
    Xenotransplantation; 2004 May; 11(3):224-5. PubMed ID: 15099198
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment of a donor pig for xenotransplantation clinical trials based on the principle of Changsha Communiqué.
    Ma X; Li S; Wang J; Xu C; Wang W
    Health Care Sci; 2023 Apr; 2(2):129-134. PubMed ID: 38938766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenotransplantation Literature Update September-October, 2005.
    Baertschiger RM; Buhler LH
    Xenotransplantation; 2006 Jan; 13(1):86-8. PubMed ID: 16497217
    [No Abstract]   [Full Text] [Related]  

  • 10. Xenotransplantation: from the lab to the clinic: Sunrise Symposium at the XXIII International Congress of the Transplantation Society, Vancouver, Canada, August 2010.
    Schuurman HJ
    Clin Transplant; 2011; 25(4):E415-21. PubMed ID: 21535153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: World Health Assembly resolution 57.18 on xenotransplantation.
    Sykes M
    Transplantation; 2005 Mar; 79(6):636-7. PubMed ID: 15785364
    [No Abstract]   [Full Text] [Related]  

  • 12. International Human Xenotransplantation Inventory: A 10-year Follow-up.
    Hu X; Geng Z; Gonelle-Gispert C; Hawthrone WJ; Deng S; Buhler L
    Transplantation; 2022 Sep; 106(9):1713-1716. PubMed ID: 34982756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary.
    Hering BJ; Cooper DK; Cozzi E; Schuurman HJ; Korbutt GS; Denner J; O'Connell PJ; Vanderpool HY; Pierson RN
    Xenotransplantation; 2009; 16(4):196-202. PubMed ID: 19799759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenotransplantation in Sweden.
    Reimer S
    Pathol Biol (Paris); 2000 May; 48(4):440-2. PubMed ID: 10868417
    [No Abstract]   [Full Text] [Related]  

  • 16. New FDA xenotransplantation documents: a proposed rule and a draft guidance.
    Bloom ET
    Xenotransplantation; 2001 Aug; 8(3):153-4. PubMed ID: 11472622
    [No Abstract]   [Full Text] [Related]  

  • 17. Xenotransplantation literature update November-December, 2004.
    Baertschiger RM; Buhler LH
    Xenotransplantation; 2005 Mar; 12(2):156-60. PubMed ID: 15693847
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO medicines expert calls for new rules against commercial bias in medical research.
    J Adv Nurs; 2002 Jun; 38(6):546. PubMed ID: 12108409
    [No Abstract]   [Full Text] [Related]  

  • 19. Position paper on the initiation of clinical trials of xenotransplantation. The American Society of Transplantation and The American Society of Transplant Surgeons.
    Xenotransplantation; 2000 Nov; 7(4):235-6. PubMed ID: 11081757
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for xenotransplantation.
    Sykes M; Sandrin M; D'Apice A;
    N Engl J Med; 2003 Sep; 349(13):1294-5. PubMed ID: 14507959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.